Vav1: an oncogene that regulates specific transcriptional activation of T cells

Shulamit Katzav1

  • 1Hubert H Humphrey Center for Experimental Medicine & Cancer Research, The Hebrew University-Hadassah Medical School, Jerusalem, Israel. katzav@cc.huji.ac.il

Blood
|November 1, 2003
PubMed

Insights

Nuclear Factor of Activated T cells (NFAT) regulation by Vav1 offers a novel therapeutic target. Targeting Vav1 may lead to more specific immunosuppressive therapies with fewer side effects.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Nuclear Factor of Activated T cells (NFAT) are key transcription factors regulated by calcineurin, a Ca2+-dependent phosphatase.
  • Current immunosuppressants like cyclosporin A (CsA) and FK506 inhibit NFAT but cause severe side effects.
  • Vav1, a guanine exchange factor (GEF) exclusively in hematopoietic cells, is a critical regulator of NFAT activity.

Purpose of the Study:

  • To review the mechanisms by which Vav1 regulates NFAT.
  • To highlight the role of Vav1 in GEF-dependent and -independent pathways.
  • To emphasize Vav1's newly identified role in regulating Ca2+ release.

Main Methods:

  • Literature review of studies on Vav1 and NFAT signaling.
  • Analysis of GEF-dependent and -independent mechanisms.
  • Examination of Vav1's role in Ca2+ signaling.

Main Results:

  • Vav1 regulates NFAT through both GEF-dependent and -independent pathways.
  • Vav1 plays a significant role in controlling Ca2+ release.
  • Vav1's specific expression in hematopoietic cells makes it an attractive target.

Conclusions:

  • Targeting Vav1, particularly its protein interactions, could enable selective modification of T-cell behavior.
  • This approach may lead to the development of more specific immunosuppressive therapies with reduced systemic toxicity.
  • Vav1 represents a promising target for next-generation immunosuppression in transplantation and autoimmune diseases.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...